Effects of D1 and D2 dopamine receptor agonists and antagonists on cerebral ischemia/reperfusion injury

Acta Physiologica Sinica

Volumn 55, Issue 5, 2003, Pages 565-570

  Zong, Xue Mei ^a,b   Zeng, Yin Ming ^b   Xu, Tie ^a   Lü, Jian Nong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Jiangsu Institute of Anesthesiology   (China)

Author keywords

Apoptosis; Bax; Bcl 2; Cerebral ischemia reperfusion injury; Dopamine; Gerbil

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PARAFFIN; PERGOLIDE; PROTEIN BAX; PROTEIN BCL 2; SPIPERONE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; GERBIL; HABITUATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NERVE INJURY; NICK END LABELING; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REPERFUSION INJURY; STAINING; ANIMAL; BIOSYNTHESIS; BRAIN; GENETICS; MALE; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSIENT ISCHEMIC ATTACK;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN ISCHEMIA; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PERGOLIDE; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REPERFUSION INJURY;

EID: 3142566453     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hashimoto N, Matsumoto T, Mabe H, Hashitani T, Nishino H. Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum. Brain Res Bull 1994;33(3):281-288.
2. Hastings TG, Lewis DA, Zigmond MJ. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 1996;93(5):1956-1961.
3. Jones DC, Gunasekar PG, Borowitz JL, Isom GE. Dopamine-induced apoptosis is mediated by oxidative stress and Is enhanced by cyanide in differentiated PC12 cells. J Neurochem 2000;74(6):2296-2304.
4. Abe K, Aoki M, Kawagoe J, Yoshida T, Hattori A, Kogure K, Itoyama Y. Ischemic delayed neuronal death. A mitochondrial hypothesis. Stroke 1995;26(8):1478-1489.
5. Colbourne F, Sutherland GR, Auer RN. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J Neurosci 1999;19 (11):4200-4210.
6. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995;15(2):1001-1011.
7. Colbourne F, Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 1995;15(11):7250-7260.
8. Hattori A, Luo Y, Umegaki H, Munoz J, Roth GS. Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats. Neuroreport 1998;9(11):2569-2572.
9. Luo Y, Hattori A, Munoz J, Qin ZH, Roth GS. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. Mol Pharmacol 1999;56(2):254-264.
10. Daily D, Barzilai A, Offen D, Kamsler A, Melamed E, Ziv I. The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. Cell Mol Neurobiol 1999;19(2): 261-276.
11. Hou ST, Cowan E, Walker T, Ohan N, Dove M, Rasqinha I, MacManus JP. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J Neurochem 2001;78(2):287-297.
12. Lud Cadet J, Harrington B, Ordonez S. Bcl-2 overexpression attenuates dopamine-induced apoptosis in an immortalized neural cell line by suppressing the production of reactive oxygen species. Synapse 2000;35(3):228-233.
13. Hou ST, Cowan E, Dostanic S, Rasquinha I, Comas T, Morley P, MacManus JP. Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons. Neurosci Lett 2001;306(3):153-156.
14. Shirvan A, Ziv I, Barzilai A, Djaldeti R, Zilkh-Falb R, Michlin T, Melamed E. Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neurons. J Neural Transm Suppl 1997;50:67-78.
15. Weinberger J, Nieves-Rosa J, Cohen G. Nerve terminal damage in cerebral ischemia: protective of alpha-methyl-para-tyrosine. Stroke 1985;16(5):864-870.
16. Caldwell MA, Reymann JM, Allain H, Leonard BE, Bentue-Ferrer D. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Res 1997;771(2):305-318.
17. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75(2):241-251.
18. 2+ fluxes. Proc Natl Acad Sci USA 1994;91(14):6569-6573.
19. Swanton E, Savory P, Cosulich S, Clarke P, Woodman P. Bcl-2 regulates a capase-3/capase-2 apoptotic cascade in cytosolic extracts. Oncogene 1999;18(10):1781-1787.
20. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79(2):189-192.